{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-28396341-linaclotide:v1","objectPathId":"pubmed-pmid-28396341-linaclotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-28396341-linaclotide/","json":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-28396341-linaclotide-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-28396341-linaclotide-v1.md"},"story":{"slug":"pubmed-pmid-28396341-linaclotide","version":1,"domain":"Literature metadata","dateInSource":"2025-01-03","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["linaclotide"],"peptides":[{"slug":"linaclotide","url":"https://peptidescanner.com/peptides/linaclotide/"}]},"claims":[{"id":"headline","text":"Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.","sourceIds":["pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9"]},{"id":"summary","text":"PubMed lists PMID 28396341 in Cancer prevention research (Philadelphia, Pa.) as Clinical Trial, Journal Article, with publication-date metadata of 2017-04-10 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9"]},{"id":"paragraph-1","text":"PubMed lists PMID 28396341 in Cancer prevention research (Philadelphia, Pa.) as Clinical Trial, Journal Article, with publication-date metadata of 2017-04-10 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9"]}],"sources":[{"id":"pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9","name":"PubMed","sourceClass":"A","title":"Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. · retained source version 1:2025-01-03:current:628404c7fcb96bf4b9797b5cfda9d78acda3083d570ad69a5a2404240b889574","url":"https://pubmed.ncbi.nlm.nih.gov/28396341/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c7dc9654fa55b09318b413f3dc1953a5af431e4870bacb976a069b39b6febba2","tierARecordSha256":"af7489b76ba0f398ec1f4a1f563782553d8bc889a978735642244a2d455668f2"},"integrity":{"algorithm":"sha256","contentSha256":"5deb397ed9a9a369ead090e30697e38ec7a5e87f4135f5fc07fb08c26ba70f90"}}